Breasy

Clinical Trials

Numerous clinical trials have established the efficacy and safety of Montelukast in asthma and allergic rhinitis across various age groups.

Lab Monitoring

• No routine lab monitoring is generally required. Liver function tests may be considered in patients with pre-existing hepatic impairment or if symptoms suggestive of liver dysfunction develop.

Doctor Notes

• Emphasize to patients that Montelukast is for long-term control and not for acute asthma relief. Instruct on proper use of rescue inhalers.
• Counsel patients and caregivers on the potential for neuropsychiatric events and the importance of reporting any changes in behavior or mood promptly.

Patient Guidelines

• Take this medicine regularly, even if you feel well, to get the most benefit.
• Do not stop taking this medicine suddenly without consulting your doctor.
• This medicine is not for treating acute asthma attacks. Always carry your rescue inhaler for sudden asthma symptoms.
• Report any mood changes, sleep disturbances, or unusual behavior to your doctor immediately.

Missed Dose Advice

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Driving Precautions

Montelukast may cause dizziness or drowsiness in some individuals. If you experience these symptoms, avoid driving or operating heavy machinery.

Lifestyle Advice

• Identify and avoid asthma triggers (e.g., pollen, dust mites, pet dander).
• Maintain a healthy weight and engage in regular physical activity as tolerated.
• Avoid smoking and exposure to secondhand smoke.
• Practice good hygiene to prevent respiratory infections.